Stock BCART BIOCARTIS GROUP NV
Add to a list
To use this feature you must be a member
Log inSign up

Financials Biocartis Group NV

Equities

BCART

BE0974281132

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Bruxelles
Other stock markets
 11:35:06 2023-09-22 am EDT 		5-day change 1st Jan Change
0.29 EUR +1.05% Intraday chart for Biocartis Group NV -.--% -.--%
2023 Biocartis Group NV Presents Four Abstracts Showing Excellent Data for Idylla at European Society of Molecular Oncology Congress CI
2023 Biocartis, APIS Assay Technologies to Commercialize Estrogen Receptor-positive Mutations Kit MT

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 610.2 510.5 322.5 267.6 208 48.52
Enterprise Value (EV) 1 532.8 482.3 310.4 294.5 308.7 144.8
P/E ratio -12.8 x -10.6 x -5.01 x -4.18 x -2.91 x -0.49 x
Yield - - - - - -
Capitalization / Revenue 26.4 x 17.8 x 8.55 x 4.82 x 3.79 x 0.84 x
EV / Revenue 23.1 x 16.8 x 8.23 x 5.3 x 5.62 x 2.5 x
EV / EBITDA -13.8 x -12.2 x -6.09 x -7.23 x -5.78 x -3.55 x
EV / FCF -18.1 x -15 x -8.21 x -14.1 x -7.44 x -5.07 x
FCF Yield -5.53% -6.66% -12.2% -7.07% -13.4% -19.7%
Price to Book 4.61 x 5.84 x 3.82 x 7.27 x -6.14 x -1.62 x
Nbr of stocks (in thousands) 51,102 51,361 56,382 57,546 57,546 91,894
Reference price 2 11.94 9.940 5.720 4.650 3.615 0.5280
Announcement Date 4/5/18 4/4/19 4/2/20 4/1/21 3/31/22 4/11/23
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 23.11 28.65 37.73 55.56 54.9 57.98
EBITDA 1 -38.61 -39.49 -50.98 -40.74 -53.38 -40.78
EBIT 1 -43.59 -43.62 -55.6 -45.16 -58.04 -45.87
Operating Margin -188.62% -152.24% -147.36% -81.29% -105.72% -79.12%
Earnings before Tax (EBT) 1 -45.32 -48.26 -64.17 -63.16 -71.72 -65.62
Net income 1 -41.96 -48.15 -64.07 -62.93 -71.47 -65.38
Net margin -181.57% -168.07% -169.8% -113.27% -130.19% -112.77%
EPS 2 -0.9294 -0.9400 -1.143 -1.112 -1.242 -1.080
Free Cash Flow 1 -29.45 -32.13 -37.82 -20.83 -41.48 -28.54
FCF margin -127.43% -112.13% -100.24% -37.49% -75.56% -49.22%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/5/18 4/4/19 4/2/20 4/1/21 3/31/22 4/11/23
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - 26.9 101 96.2
Net Cash position 1 77.4 28.2 12.1 - - -
Leverage (Debt/EBITDA) - - - -0.66 x -1.885 x -2.36 x
Free Cash Flow 1 -29.4 -32.1 -37.8 -20.8 -41.5 -28.5
ROE (net income / shareholders' equity) -36.6% -43.9% -74.6% -104% -4,884% 204%
ROA (Net income/ Total Assets) -16.9% -17% -17% -11.8% -20.6% -22.3%
Assets 1 248.4 283.1 375.8 533.8 347.8 292.8
Book Value Per Share 2 2.590 1.700 1.500 0.6400 -0.5900 -0.3300
Cash Flow per Share 2 2.210 1.240 3.170 2.150 0.9300 0.2800
Capex 1 3.16 5.57 2.12 3.01 3.69 1.57
Capex / Sales 13.66% 19.44% 5.62% 5.41% 6.71% 2.71%
Announcement Date 4/5/18 4/4/19 4/2/20 4/1/21 3/31/22 4/11/23
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Medical Equipment

1st Jan change Capi.
BIOCARTIS GROUP NV Stock Biocartis Group NV
-.--% 29.08M
SHOCKWAVE MEDICAL, INC. Stock Shockwave Medical, Inc.
+73.17% 12.38B
PENUMBRA, INC. Stock Penumbra, Inc.
-18.74% 7.92B
MASIMO CORPORATION Stock Masimo Corporation
+16.15% 7.2B
GETINGE AB Stock Getinge AB
+4.81% 5.84B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+5.99% 5.01B
APT MEDICAL INC. Stock APT Medical Inc.
+27.07% 4.53B
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-21.67% 3.88B
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-40.82% 2.23B
SKAN GROUP AG Stock SKAN Group AG
+1.49% 2.02B
Medical Equipment
  1. Stock Market
  2. Equities
  3. BCART Stock
  4. Financials Biocartis Group NV